Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the design, development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems ...

Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million

Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the design, development and commercialization of glucose monitoring products designed to transform lives in the global ...
Stocktwits on MSN

The $5 signal: Why Senseonics’ capital raise is dragging SENS stock down

Senseonics priced 8 million shares at $5.00 and 8 million pre-funded warrants at $4.999, with each warrant exercisable for a ...

Senseonics shares sink Friday: What's driving the move?

Shares of Senseonics Holdings Inc SENS are trading sharply lower Friday morning following the late-Thursday announcement of ...
Business Wire

Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous ...
American Association of Individual Investors

Why Senseonics Holdings, Inc.’s (SENS) Stock Is Down 5.98%

As of Wednesday, April 29, Senseonics Holdings, Inc.’s SENS share price has dipped by 5.98%, which has investors questioning ...
Business Wire

Senseonics Announces CFO Transition

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous ...
FierceBiotech

Sequel Med Tech to link Senseonics’ 365-day CGM with upcoming twiist insulin pump

Senseonics and newcomer pump developer Sequel Med Tech have a plan to connect their diabetes technologies, with the goal of delivering what they describe as the first automated insulin delivery system ...
FierceBiotech

Senseonics' Eversense 180-day glucose sensor scores new European approval

After rolling out in the U.S. earlier this year, Senseonics’ six-month Eversense E3 continuous glucose monitor is going international with European approval. Distributed globally by Ascensia Diabetes ...
The Bakersfield Californian

Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for ...

Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable continuous glucose monitoring ...
Nasdaq

Senseonics to sell 45.7M shares at 35c in registered direct offering

Senseonics (SENS) Holdings has entered into a definitive agreement for the purchase and sale of 45,714,286 shares of its common stock at an offering price of $0.35 per share of common stock in a ...
Nasdaq

Senseonics Q4 Revenue Jumps 72%, Expects FY26 Revenue To Grow 65-76%

(RTTNews) - Senseonics Holdings, Inc. (SENS), a commercial-stage medical technology company, reported fourth-quarter and full-year results with revenue growth. The company expects full year 2026 ...